Navigation Links
They were right after all
Date:1/31/2008

This release is also available in German.

Drugs derived from cinchona bark, known as cinchona alkaloids, have been used in healing from ancient times. The most prominent representative of this group is quinine, a bitter substance contained in beverages such as tonic water and used in modern medicine to combat malaria. As early as 1945, Robert Burns Woodward and William von Eggers Doering (Harvard University) described how to synthesize quinine in the laboratory. The last step of this formal total synthesis, a three-step reaction procedure previously described by Paul Rabe and Karl Kindler in 1918, has continued to be the subject of much controversy to this day. Aaron C. Smith and Robert M. Williams at Colorado State University (USA) have now successfully reproduced the RabeKindler protocol. As described in an Angewandte Chemie article dedicated to Doering on his 90th birthday, they repeated the entire procedure without employing any modern methods.

Had they done it or not? That has been the question for decades. Woodward and Doering published the synthesis of d-quinotoxine in 1944. Based on the conversion of d-quinotoxine into quinine described by Rabe and Kindler in 1918, they claimed to have derived the total synthesis of quinine, though they had not actually completed this last step themselves before publishing. Their formal total synthesis was strongly challenged and was even dismissed as a myth by Gilbert Stork (Columbia University) in 2001.

Quinine and the cinchona bark alkaloids play an important role in modern medicine. It is thus amazing that no attempts to reproduce the RabeKindler conversion of quinotoxine into quinine have been published, marvels Williams. Smith and Williams reviewed the old publications, researched further references, and set themselves the task of repeating the procedure outlined by Rabe and Kindlerand with techniques available at the time. Initially, the yield of quinine they obtained was far too low. The key turned out to be the aluminum powder used as a reducing agent in the last step. It must not be too fresh, instead it must be exposed to air for a while first to produce a small amount of aluminum oxide. This results in yields of quinine in agreement with those in the old publications.

Analytically pure quinine can be isolated from this reaction by the selective crystallization of the corresponding tartrate salt, just as described by Rabe in 1939, says Williams. We have thus corroborated Rabe and Kindlers 1918 publication. Woodward and Doering could theoretically also have followed this procedure in 1944.


'/>"/>

Contact: Robert M. Williams
rmw@chem.colostate.edu
970-491-6747
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Bright Options for Medicare Beneficiaries in Louisiana
2. A Bright Future for Medicare Beneficiaries in Maine
3. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
4. Phony Physicians Committee Suing Restaurants is Animal-Rights Trojan Horse, says CCF
5. Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights
6. Brighton Hospital Announces Creation of Brighton National Addiction Foundation
7. Exercise Your Right to Vote and Continue to Make a Difference by Giving Blood in 2008
8. AARP Calls New EEOC Policy A Civil Rights and Economic Fiasco
9. Make 2008 the Year to Find an Insurance Agent Thats Right for You
10. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... Melbourne, Australia (PRWEB) , ... February 24, 2017 , ... ... Press AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema ... post-traumatic stress disorder and his attempts to overcome them. , Schanssema, initially unsure ...
(Date:2/24/2017)... ... 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly C. ... Dyer started as the Chairman of the Management Committee when IFN was originally formed ... the recruitment of investor/owners and development of the business plan. He became the ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the ... The Jensie Gran Fondo of Marin. For the second year in a row, ... mineral-based sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical ... products for the urology market, will release financial results ... 31, 2016 before the market open on Thursday, March ... a conference call and webcast to discuss its financial ... at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
Breaking Medicine Technology: